Each year there are 1 million new cases of shingles in the US, and 1 in 3 adults will develop it in their lifetime. Risk of contracting shingles increases with age, with half of all cases occurring in persons over age 60. Shingles can also lead to complications such as postherpetic neuralgia, blindness, cranial and peripheral nerve palsies, and disseminated infection.
There are currently two approved shingles vaccinations, with the zoster vaccine, recombinant adjuvanted (RZV) being preferred by the Advisory Committee on Immunization Practices (ACIP). Patients are often unaware of the risk imposed by shingles as well as the availability of vaccines. To reduce the profound burden imposed by shingles, it is imperative that clinicians possess the tools needed to successfully implement a shingles protocol in their practice. These tools include identifying at-risk patients, taking advantage of CDC toolkits and checklists, offering strong recommendations for vaccination, and incorporating systems in place to improve vaccine uptake and completion.
This CMEOCast podcast focuses on best practices to increase vaccine uptake and completion in vaccine-eligible patients and those at risk who present to specialty settings. The podcast will address ideal strategies to store and administer RZV, counseling patients on the extensive burden associated with shingles, and the benefits and potential risks of vaccination.
At the end of this CME/CE activity, participants should be able to develop best practices to implement a shingles protocol in specialty practice settings.
The following learning objectives pertain only to those requesting CNE or CPE credit: Explain best practices to implement a shingles protocol in specialty practice settings.
This educational activity is supported by an educational grant from GlaxoSmithKline.
Physicians, PAs, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Schaffner has no disclosures to report.
Dr. Auwaerter has no disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-134-H06-P.
Call us at 877.CME.PROS (877.263.7767).